DBCCF moved above its 50-day moving average on November 19, 2024 date and that indicates a change from a downward trend to an upward trend. In of 60 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 19, 2024. You may want to consider a long position or call options on DBCCF as a result. In of 140 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for DBCCF just turned positive on December 20, 2024. Looking at past instances where DBCCF's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DBCCF advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 134 cases where DBCCF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBCCF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
DBCCF broke above its upper Bollinger Band on December 23, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DBCCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.199) is normal, around the industry mean (58.252). P/E Ratio (37.453) is within average values for comparable stocks, (90.460). DBCCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.622) is also within normal values, averaging (19.472).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBCCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry PharmaceuticalsOther
A.I.dvisor tells us that DBCCF and AYTU have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBCCF and AYTU's prices will move in lockstep.
Ticker / NAME | Correlation To DBCCF | 1D Price Change % | ||
---|---|---|---|---|
DBCCF | 100% | -1.52% | ||
AYTU - DBCCF | 21% Poorly correlated | +3.45% | ||
ESALF - DBCCF | 15% Poorly correlated | -2.64% | ||
GBHPF - DBCCF | 9% Poorly correlated | N/A | ||
CXXIF - DBCCF | 2% Poorly correlated | +1.72% | ||
CRLBF - DBCCF | 2% Poorly correlated | -1.79% | ||
More |